Bioinformatics analysis (GEPIA) demonstrated that AGD1 positively correlates with CD44 and METTL13 expression, and METTL13 similarly correlates with CD44 expression in patients with PCa (Fig. 6J). The gene discussed is METTL13; the disease is posterior cortical atrophy.